Prediction of Recurrent Pregnancy Loss by a New Thrombophilia Based Genetic Risk Score

CompletedOBSERVATIONAL
Enrollment

364

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

January 31, 2017

Conditions
Miscarriage, Recurrent
Trial Locations (8)

28029

Instituto Salud Carlos III, Madrid

28040

Hospital Universitario Fundación Jiménez Díaz, Madrid

31008

Clinica Universitaria de Navarra, Pamplona

46015

IVI-RMA Valencia, Valencia

46026

Instituto de Investigaciones Sanitarias La Fe, Valencia

08950

Gendiag.exe, S.L., Esplugues de Llobregat

08025

Institut d'Investigació Sant Pau, Barcelona

W1G9RQ

IVI-RMA-London, London

All Listed Sponsors
collaborator

Clinica Universidad de Navarra, Universidad de Navarra

OTHER

collaborator

Instituto de Salud Carlos III

OTHER_GOV

collaborator

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

OTHER

collaborator

Instituto Valenciano de Infertilidad, IVI VALENCIA

OTHER

collaborator

IVI-RMA London

UNKNOWN

collaborator

Instituto de Investigacion Sanitaria La Fe

OTHER

collaborator

Gendiag.exe, S.L.

UNKNOWN

collaborator

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

lead

Ferrer inCode, S.L.

INDUSTRY

NCT03336463 - Prediction of Recurrent Pregnancy Loss by a New Thrombophilia Based Genetic Risk Score | Biotech Hunter | Biotech Hunter